Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 29:2024:baae053.
doi: 10.1093/database/baae053.

ISTransbase: an online database for inhibitor and substrate of drug transporters

Affiliations

ISTransbase: an online database for inhibitor and substrate of drug transporters

Jinfu Peng et al. Database (Oxford). .

Abstract

Drug transporters, integral membrane proteins found throughout the human body, play critical roles in physiological and biochemical processes through interactions with ligands, such as substrates and inhibitors. The extensive and disparate data on drug transporters complicate understanding their complex relationships with ligands. To address this challenge, it is essential to gather and summarize information on drug transporters, inhibitors and substrates, and simultaneously develop a comprehensive and user-friendly database. Current online resources often provide fragmented information and have limited coverage of drug transporter substrates and inhibitors, highlighting the need for a specialized, comprehensive and openly accessible database. ISTransbase addresses this gap by amassing a substantial amount of data from literature, government documents and open databases. It includes 16 528 inhibitors and 4465 substrates of 163 drug transporters from 18 different species, resulting in a total of 93 841 inhibitor records and 51 053 substrate records. ISTransbase provides detailed insights into drug transporters and their inhibitors/substrates, encompassing transporter and molecule structure, transporter function and distribution, as well as experimental methods and results from transport or inhibition experiments. Furthermore, ISTransbase offers three search strategies that allow users to retrieve drugs and transporters based on multiple selectable constraints, as well as perform checks for drug-drug interactions. Users can also browse and download data. In summary, ISTransbase (https://istransbase.scbdd.com/) serves as a valuable resource for accurately and efficiently accessing information on drug transporter inhibitors and substrates, aiding researchers in exploring drug transporter mechanisms and assisting clinicians in mitigating adverse drug reactions Database URL: https://istransbase.scbdd.com/.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Graphical abstract of ISTransbase. ISTransbase provides comprehensive and detailed information on drug transporters and their inhibitors/substrates.
Figure 2.
Figure 2.
Statistics on the inhibitors and substrates of transporters. (A) Distribution of data sources in ISTransbase. (B) Distribution of inhibitors and substrates, and their entries of ISTransbase. (C) Inhibitors and substrates per transporters. Data were sourced from literature (33%), government reports (25%) and open databases (A). The database includes a comprehensive list of transporter inhibitors and substrates (B), covering 163 transporters from 18 species. This includes 17 ATP-binding cassette (ABC) transporters and 132 solute carrier (SLC) transporters (C).
Figure 3.
Figure 3.
Statistics on research methods and parameters of transporter inhibitors and substrates. (A) Research methods and in vitro experimental system of inhibitor and substrate studies. (B) Distribution of in vivo and in vitro parameters of inhibitors and substrates. Analysis shows a higher prevalence of in vitro data for inhibitors (93%) and substrates compared to in vivo data (77%) (A). The most reported in vitro inhibition parameter is IC50 (40%). For substrates, the leading parameter is apparent permeability (Papp) (29%). In vivo studies mainly focus on the area under the concentration-time curve (AUC) for both inhibitors and substrates (B).
Figure 4.
Figure 4.
The main search page of ISTransbase. ISTransbase offers three search strategies that allow users to retrieve drugs and transporters based on multiple selectable constraints, as well as perform checks for drug–drug interactions.
Figure 5.
Figure 5.
ISTransbase search result pages of Drug2Transporters mode. (A) Search results of drug2transporters mode (Colchicine: COC1 = CC = C2C(=CC1 = O)[C@H](CCC1 = CC(OC) = C(OC)C(OC) = C21)NC(C) = O). (B) Page with detailed information on drug transporters (OCT1). (C) Detailed view of Colchicine’s transport information mediated by the transporter MDR1.
Figure 6.
Figure 6.
ISTransbase search result pages of Transporters2Drug and Drug-Drug Checker mode. (A) Search result of Transporters2Drug mode (OCT1). (B) Search result of Drug-Drug Checker mode (drug A: rosuvastatin, drug B: rifampin).

Similar articles

References

    1. Cheng Y., El-Kattan A., Zhang Y. et al. (2016) Involvement of drug transporters in organ toxicity: the fundamental basis of drug discovery and development. Chem. Res. Toxicol., 29, 545–563. - PubMed
    1. Yang X., Ma Z., Zhou S. et al. (2016) Multiple drug transporters are involved in renal secretion of entecavir. Antimicrob. Agents Chemother., 60, 6260–6270. - PMC - PubMed
    1. Kitamura S., Maeda K., Wang Y. et al. (2008) Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab. Dispos., 36, 2014–2023. - PubMed
    1. Nigam S.K. (2014) What do drug transporters really do? What do drug transporters really do? Nat. Rev: Drug Discov., 14, 29–44. - PMC - PubMed
    1. König J., Müller F. and Fromm M.F. (2013) Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol. Rev., 65, 944–966. - PubMed

Substances